Received Oct 30, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | EH9899 | RA |
Pain, swelling, increased warmth at injection site; Pain, swelling, increased warmth at injection site; Pain, swelling, increased warmth at injection site; Fever; Headache; body aches; chills; fatigue; stiffness multiple bilateral joints; swelling, pain, stiffness multiple bilateral joints; swelling, pain, stiffness multiple bilateral joints; This is a spontaneous report received from a Consumer or other non HCP. An adult female patient received BNT162b2 (BNT162B2), as dose 1, single (Lot number: EH9899), in right arm for covid-19 immunisation. Vaccination date of dose 1 was 21Dec2021 (as reported). The patient's relevant medical history included: "Intolerant to non-specific beta blockers" (unspecified if ongoing); "Intolerant to non-specific beta blockers" (unspecified if ongoing). The patient's concomitant medications were not reported. Past drug history included: Nitroglycerin, reaction(s): "allergies:nitroglycerin". The following information was reported: VACCINATION SITE PAIN (non-serious), VACCINATION SITE SWELLING (non-serious), VACCINATION SITE WARMTH (non-serious), outcome "recovered" and all described as "Pain, swelling, increased warmth at injection site"; PYREXIA (non-serious), outcome "recovered", described as "Fever"; HEADACHE (non-serious), outcome "recovered"; PAIN (non-serious), outcome "recovered", described as "body aches"; CHILLS (non-serious), outcome "recovered"; FATIGUE (non-serious), outcome "recovered"; JOINT STIFFNESS (non-serious), outcome "recovered", described as "stiffness multiple bilateral joints"; JOINT SWELLING (non-serious), ARTHRALGIA (non-serious), outcome "recovered" and all described as "swelling, pain, stiffness multiple bilateral joints". Additional information: The reaction to the first dose were less severe with shorter duration of acute symptoms. The second dose was given on 11Jan2021. No follow-up attempts are possible.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202500211948 same patient/suspect vaccine; different dose/AE.;
Medical History/Concurrent Conditions: Drug allergy; Drug intolerance